Postpartum Anemia
Conditions
Brief summary
Anemia diagnosis by hemoglobin level monitoring in women after vaginal delivery by symptoms versus screening of women at increased risk for post-partum anemia.
Detailed description
Anemia is common following delivery. It is associated with some serious complications including increased risk for syncope and in severe cases even cardiogenic shock. Yet, anemia-associated symptoms might manifest relatively late after the patient have lost a fair amount of blood, which was not diagnosed early enough. To date, there are not acceptable guidelines for monitoring hemoglobin levels after delivery. Theoretically, there are 2 approaches for hemoglobin monitoring - one by taking hemoglobin levels in order to diagnose anemia in patients reporting anemia-associated symptoms. The other approach is by screening of women at increased risk for post-partum anemia. In the present study we aimed to compare those 2 approaches.
Interventions
OTHERMonitoring hemoglobin levels following anemia associated symptoms
Post-partum anemia will be diagnosed after vaginal delivery by taking hemoglobin levels to patients with symptoms consistent with anemia, severe postpartum hemorrhage or hemoglobin level below 8 g/dL.
OTHERMonitoring hemoglobin levels to detect anemia by screening of women at increased risk for post partum anemia
Post-partum anemia will be diagnosed after vaginal delivery by taking hemoglobin levels to high risk women for post-partum anemia, defined as hemoglobin levels of 10.5 g/dl or below around delivery, or severe postpartum hemorrhage with or without symptoms associated with anemia
Sponsors
HaEmek Medical Center, Israel
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* pregnant women after vaginal delivery
Exclusion criteria
* pregnant women with known sensitivity to the product iron sucrose * pregnant women after cesarean section
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The rate of patients diagnosed with anemia | Up to 3 days postpartum | Hemoglobin of 10 g/dl or below |
| The rate of patients who received treatment with intravenous iron sucrose | Up to 3 days postpartum | — |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The rate of women who underwent uterine revision following delivery after their arrival to the maternity ward | From delivery and up to 5 days | — |
| The rate of women who needed uterotonic agents after their arrival to the maternity ward | From delivery and up to 5 days | — |
| The average blood tests number that was performed | From delivery and up to 5 days | — |
| The rate of patients who received blood transfusion | From delivery and up to 5 days | — |
| The composite symptoms of anemia and functional capacity after 6 weeks postpartum as assessed by a questionnaire | 6 weeks postpartum | Each question in the questionnaire will receive a score. The total score will be reported. |
| Hemoglobin level 6 weeks postpartum | 6 weeks postpartum | — |
| Minimal and average hemoglobin level | From delivery and up to 5 days | — |
| The rate of women with post-partum hemorrhage | From delivery and up to 5 days | — |
Countries
Israel
Outcome results
None listed